OBJECTIVES: The objectives of this study are to assess (a) the level of depressive symptoms among a cohort of HIV infected women and comparable controls and (b) the relationship with covariates including socioeconomic status, substance use, social relations, disease status. METHODS: Participants were enrolled in the Women's Interagency HIV Study (WIHS). Depressive symptoms were measured using the Center for Epidemiological Studies Depression Scale (CESD). Data from 1993 HIV seropositive and 551 seronegative women are presented. RESULTS: Of HIV positive women 57.7% of HIV positive women scored 16 or higher on the CESD (ns) as compared to 55.0% of HIV negative women; at a cutoff of 23, the percents were 40.4% and 35.9% respectively (p = .06). The mean score was high 19.8 but not significantly different between groups. Scores were higher among women who had less education, lower income, were of Hispanic ethnicity, used alcohol or drugs, experienced domestic abuse, had more than one partner, or had less supportive relationships. Among infected women, higher CESD scores were not significantly associated with CD4 cell count but were elevated for self-reported Class C AIDS defining clinical conditions. CONCLUSIONS: The scores on the CESD were elevated for both HIV positive and HIV negative women and the differences between the groups were small. Lower socioeconomic status and social support and higher substance use and domestic abuse were associated with depressive symptoms similarly for both groups.
OBJECTIVES: The objectives of this study are to assess (a) the level of depressive symptoms among a cohort of HIV infectedwomen and comparable controls and (b) the relationship with covariates including socioeconomic status, substance use, social relations, disease status. METHODS:Participants were enrolled in the Women's Interagency HIV Study (WIHS). Depressive symptoms were measured using the Center for Epidemiological Studies Depression Scale (CESD). Data from 1993 HIV seropositive and 551 seronegative women are presented. RESULTS: Of HIV positive women 57.7% of HIV positive women scored 16 or higher on the CESD (ns) as compared to 55.0% of HIV negative women; at a cutoff of 23, the percents were 40.4% and 35.9% respectively (p = .06). The mean score was high 19.8 but not significantly different between groups. Scores were higher among women who had less education, lower income, were of Hispanic ethnicity, used alcohol or drugs, experienced domestic abuse, had more than one partner, or had less supportive relationships. Among infected women, higher CESD scores were not significantly associated with CD4 cell count but were elevated for self-reported Class C AIDS defining clinical conditions. CONCLUSIONS: The scores on the CESD were elevated for both HIV positive and HIV negative women and the differences between the groups were small. Lower socioeconomic status and social support and higher substance use and domestic abuse were associated with depressive symptoms similarly for both groups.
Authors: Leah H Rubin; Judith A Cook; Dennis D Grey; Kathleen Weber; Christina Wells; Elizabeth T Golub; Rodney L Wright; Rebecca M Schwartz; Lakshmi Goparaju; Deborah Cohan; Melissa L Wilson; Pauline M Maki Journal: J Womens Health (Larchmt) Date: 2011-07-06 Impact factor: 2.681
Authors: Uraina S Clark; Keenan A Walker; Ronald A Cohen; Kathryn N Devlin; Anna M Folkers; Matthew J Pina; Karen T Tashima Journal: Neuropsychologia Date: 2015-03-03 Impact factor: 3.139
Authors: Bushra Sabri; Richelle Bolyard; Akosoa L McFadgion; Jamila K Stockman; Marguerite B Lucea; Gloria B Callwood; Catherine R Coverston; Jacquelyn C Campbell Journal: Soc Work Health Care Date: 2013
Authors: Basmattee Boodram; Michael W Plankey; Christopher Cox; Phyllis C Tien; Mardge H Cohen; Kathryn Anastos; Roksana Karim; Charles Hyman; Ronald C Hershow Journal: AIDS Patient Care STDS Date: 2009-12 Impact factor: 5.078
Authors: Michael J Silverberg; Mary Elizabeth Gore; Audrey L French; Monica Gandhi; Marshall J Glesby; Andrea Kovacs; Tracey E Wilson; Mary A Young; Stephen J Gange Journal: Clin Infect Dis Date: 2004-08-16 Impact factor: 9.079